• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎 17 例临床特征。

Clinical features of 17 patients with 2019-nCoV.

机构信息

Zhengzhou People's Hospital, Zhengzhou, China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10896-10901. doi: 10.26355/eurrev_202010_23454.

DOI:10.26355/eurrev_202010_23454
PMID:33155253
Abstract

OBJECTIVE

This study aims to discuss the unique clinical features of patients with 2019-nCoV in Zhengzhou City to provide references for clinical diagnosis and treatment.

PATIENTS AND METHODS

Seventeen patients with 2019-nCoV in Zhengzhou People's Hospital from February to March 2020 were collected. Their epidemiology, clinical symptoms, laboratory examinations, and chest CT images were reviewed. All 17 patients were aged between 12-83 years, with an average age of 47 years, and consisted of 10 males (58.8%) and 7 females (41.2%). Two patients had histories of living or traveling in Wuhan, and 9 patients were attacked locally. The 6 remaining patients were unknown about incidence reasons.

RESULTS

The average incubation period was 10 days, and the average time of the course of the disease was 9 days. Among the participants, 12 patients had fever as the first symptoms and 5 patients had normal body temperature. One patient was symptom-free carrier, and one patient had serious symptoms. One patient developed from mild symptoms to severe symptoms, and 14 patients had mild symptoms. Moreover, 7 patients had complications of cardiovascular and cerebrovascular diseases and hypertension, 1 patient was in the advanced stage of squamous cell lung carcinoma, and 1 patient had diabetes mellitus, renal failure, and late-stage uremia. According to novel coronavirus nucleic acid test, 8 patients were positive, accounting for 47.1%. All patients were negative in the novel coronavirus IgM antibody test and negative in other common respiratory pathogen detection. All 17 patients had ground glass-like high-density shadow or stripped high-density shadow on lung CT images, accompanied with many affected lesions on two lungs. The average stay in hospital was 10 days, and the average time of the course of the disease was 9 days. After hospitalization, 15 patients were discharged from the hospital upon recovery, 1 patient was transferred to superior hospital for continuous treatment, and 1 patient died. Patients with 2019-nCoV in Zhengzhou People's Hospital were mainly attacked in local areas, and most of them had mild symptoms. The positive rate of the nucleic acid test was 47.1%.

CONCLUSIONS

The main clinical characteristics are increased neutrophil granulocytes, increased C-reactive proteins, decreased lymphocytes, ground glass-like or stripped lesions on lung CT image, common complications of cardiovascular and cerebrovascular diseases, and favorable prognosis.

摘要

目的

探讨郑州市 2019 新型冠状病毒(2019-nCoV)感染患者的临床特点,为临床诊治提供参考。

方法

收集 2020 年 2 月至 3 月郑州市人民医院收治的 17 例 2019-nCoV 感染患者的流行病学、临床症状、实验室检查和胸部 CT 影像等资料。所有患者年龄 12~83 岁,平均年龄 47 岁;男 10 例(58.8%),女 7 例(41.2%);2 例有武汉居住史或旅行史,9 例本地发病,6 例发病原因不详。

结果

潜伏期平均 10 天,发病至入院时间平均 9 天。首发症状以发热为主 12 例,体温正常 5 例。无症状感染者 1 例,重症患者 1 例。从轻症发展为重症 1 例,轻症 14 例。合并心血管、脑血管疾病及高血压者 7 例,晚期肺鳞癌 1 例,糖尿病、肾衰竭、尿毒症晚期 1 例。新型冠状病毒核酸检测 8 例阳性,占 47.1%;新型冠状病毒 IgM 抗体检测均为阴性,其他常见呼吸道病原体检测均为阴性。17 例患者胸部 CT 影像均表现为磨玻璃样高密度影或条索状高密度影,双肺多发病变,病变累及范围较广。住院时间平均 10 天,平均发病至出院时间 9 天。痊愈出院 15 例,转上级医院继续治疗 1 例,死亡 1 例。郑州市人民医院收治的 2019-nCoV 感染患者以本地发病为主,多为轻症,核酸检测阳性率为 47.1%。

结论

郑州市人民医院 2019-nCoV 感染患者以本地发病为主,多为轻症,以发热、白细胞及中性粒细胞增高、淋巴细胞降低、胸部 CT 影像呈磨玻璃样或条索状病变为主要表现,合并常见的心脑血管疾病并发症,预后良好。

相似文献

1
Clinical features of 17 patients with 2019-nCoV.新型冠状病毒肺炎 17 例临床特征。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10896-10901. doi: 10.26355/eurrev_202010_23454.
2
[CT imaging analysis of 33 cases with the 2019 novel coronavirus infection].[33例2019新型冠状病毒感染的CT影像分析]
Zhonghua Yi Xue Za Zhi. 2020 Apr 7;100(13):1007-1011. doi: 10.3760/cma.j.cn112137-20200203-00182.
3
[Analysis of CT features of 15 children with 2019 novel coronavirus infection].[15例2019新型冠状病毒感染儿童的CT特征分析]
Zhonghua Er Ke Za Zhi. 2020 Apr 2;58(4):275-278. doi: 10.3760/cma.j.cn112140-20200210-00071.
4
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020.2020 年湖北省武汉市周边地区 COVID-19 的流行病学和临床特征分析。
Pharmacol Res. 2020 Jul;157:104821. doi: 10.1016/j.phrs.2020.104821. Epub 2020 Apr 30.
5
[Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].新型冠状病毒肺炎的临床特征及高分辨率CT影像学演变
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):509-515. doi: 10.3760/cma.j.cn112147-20200214-00094.
6
[Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province].[河南省南阳市150例2019新型冠状病毒感染病例的临床分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):503-508. doi: 10.3760/cma.j.cn112147-20200224-00168.
7
Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.人工智能辅助分析 COVID-19 的临床特征和影像征象。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8210-8218. doi: 10.26355/eurrev_202008_22510.
8
Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China.中国黄冈和泰安 194 例 COVID-19 患者的临床特征。
Infection. 2020 Oct;48(5):687-694. doi: 10.1007/s15010-020-01440-5. Epub 2020 May 10.
9
Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.2019新型冠状病毒感染患者队列中与疾病进展相关的危险因素。
Ann Palliat Med. 2020 Mar;9(2):428-436. doi: 10.21037/apm.2020.03.26. Epub 2020 Mar 17.
10
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.

引用本文的文献

1
Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.评估关注的 SARS-CoV-2 变异株的潜伏期、序列间隔和代时变化:系统评价和荟萃分析。
BMC Med. 2023 Sep 29;21(1):374. doi: 10.1186/s12916-023-03070-8.
2
Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis.新型严重急性呼吸综合征冠状病毒 2 株引起的 COVID-19 的潜伏期:系统评价和荟萃分析。
JAMA Netw Open. 2022 Aug 1;5(8):e2228008. doi: 10.1001/jamanetworkopen.2022.28008.
3
The incubation period during the pandemic of COVID-19: a systematic review and meta-analysis.
COVID-19 大流行期间的潜伏期:系统评价和荟萃分析。
Syst Rev. 2021 Apr 8;10(1):101. doi: 10.1186/s13643-021-01648-y.